delete AMENDMENTS CONSEQUENTIAL ON ARTICLES 5 AND 6
This Order amends the Medicines Act 1968 to revise the regulatory framework for responsible pharmacists and superintendent pharmacists in retail pharmacy businesses. Key changes include: creating an exemption from the responsible pharmacist requirement when no medicinal products are being sold or dispensed; transferring rulemaking authority from Ministers to the General Pharmaceutical Council (Great Britain) and Pharmaceutical Society of Northern Ireland; adding a proportionality principle requiring minimum necessary burdens; allowing continued general sale list medicine sales during pharmacist absence; imposing new senior manager requirements and a 'safe and effective running' duty on superintendent pharmacists; and revoking the 2008 Regulations with transitional provisions. The Order extends to all UK jurisdictions.
While this Order introduces some burden-reducing measures (exemptions when no medicines are sold, GSL sales during absence, proportionality principle), it overall expands regulatory complexity in pharmacy by adding prescriptive senior manager requirements for superintendents, vague 'safe and effective running' duties creating expanded liability exposure, and new professional responsibility standards. The shift from parliamentary-level regulations to professional body rules reduces democratic accountability without clear evidence of benefit. The pharmacy regulatory regime fundamentally restricts who may operate a retail pharmacy business and how—with no demonstrated market failure justifying these additional constraints. Many provisions are vague enough to create compliance uncertainty and litigation risk. A more genuinely liberal approach would be to simplify rather than complicate this regulatory structure.